This page is an unofficial mirror and is not legal advice. Verify the document against the official source before relying on it.
SB606: relative to insurance coverage for biomarker testing.
Bill details
No mirrored bill text is available for this bill yet. Use the official source links below for the full current record.
Version history, amendments, and roll-call votes were not present in the imported local bill data.
Official links
SB606: relative to insurance coverage for biomarker testing.
Related law links
RSA references from bill data
-
167
· amend
· effective 2027-07-01
approve or deny a prior authorization request and notify the beneficiary, and the ordering health care provider. 2 New Section; Medicaid Coverage of Biomarker Testing. Amend RSA 167 by inserting after section 4-f the following new section: 167:4-g Biomarker Testing; Medicaid Coverage Requirements. I. The state Medicaid plan shall cover biomarker testing, as defined in RSA 420-J:27, II, in a
-
167:4
· reference
· effective 2027-07-01
iomarker coverage within RSA 420-J, which is typically reserved for non-Medicaid insurance mandates. Section 2 duplicates much of the language of section 1, but locates it within RSA 167:4, which governs eligibility for certain types of public assistance. It is unclear whether this duplication was intentional. Regardless, the bill takes effect on July 1, 2027, so any budgetary impact would not occur unt
-
420-J
· amend
· effective 2027-07-01
for biomarker testing. Be it Enacted by the Senate and House of Representatives in General Court convened: 1 New Subdivision; Managed Care Law; Biomarker Testing. Amend RSA 420-J by inserting after section 26 the following new subdivision: Biomarker Testing 420-J:27 Definitions. In this subdivision: I. “Biomarker” means a characteristic that is objectively measured and evaluated as an indi
-
420-J:27
· add
· effective 2027-07-01
r section 4-f the following new section: 167:4-g Biomarker Testing; Medicaid Coverage Requirements. I. The state Medicaid plan shall cover biomarker testing, as defined in RSA 420-J:27, II, in accordance with the requirements of this section when the biomarker test is determined as medically necessary by the New Hampshire Medicaid program for the beneficiary. II. Biomarker testing shall be covered